The Medicare Payment Advisory Commission yesterday issued its June report to Congress on refinements to Medicare payment systems and issues affecting the Medicare program, including broader changes in health care delivery and the market for health care services.

Topics include value-based payment and accountable care organizations; replacing the Medicare Advantage quality bonus program; the impact of 21st Century Cures Act changes to risk adjustment for Medicare Advantage enrollees; realigning incentives in Medicare Part D; separately payable drugs in the hospital outpatient prospective payment system; and improving Medicare’s end-stage renal disease prospective payment system.

The Medicaid and CHIP Payment and Access Commission also issued its June report to Congress yesterday.

Topics include how to better integrate care for beneficiaries who have both Medicaid and Medicare coverage; increasing enrollment in Medicare savings programs that use Medicaid funds to cover certain Medicare costs for low-income beneficiaries; Medicaid’s role in maternal health; and ensuring that Medicaid remains the payer of last resort when beneficiaries have other sources of coverage.

Related News Articles

Headline
The AHA Jan. 31 commended Sens. Bill Cassidy, R-La., Catherine Cortez Masto, D-Nev., John Cornyn, R-Texas., and Michael Bennet, D-Colo., on draft legislation…
Headline
The White House Office of Management and Budget Jan. 29 rescinded a memo it issued two days earlier directing federal agencies to temporarily pause federal…
Headline
An analysis by KFF released Jan. 28 found that Medicare Advantage insurers made nearly 50 million prior authorization determinations in 2023. The finding…
Headline
The White House Office of Management and Budget late Jan. 27 issued a memo directing federal agencies to temporarily pause federal grants, loans and other…
Headline
The AHA Jan. 27 voiced support for the Centers for Medicare & Medicaid Services proposed rule on policy and technical changes to Medicare Advantage and…
Headline
The Department of Health and Human Services Jan. 17 announced 15 Medicare Part D drugs selected for the latest round of price negotiations. Negotiations will…